1 asset in Ovarian Granulosa Cell Tumor
Therapeutic assets addressing Ovarian Granulosa Cell Tumor, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Nirogacestat Ovarian Granulosa Cell Tumor | SpringWorks Therapeutics, Inc. | P2 | CCC (50) |